PDE4A and chronic obstructive pulmonary disease: PDE4 inhibitors have shown potent anti-inflammatory properties in several cell types implicated in COPD pathogenesis (with the exception of alveolar macrophages which show a low PDE4 expression [39,40]), and can decrease the cellular oxidative stress generated by cigarette smoke and RSV as we previously outlined [3,9,23].